Alaunos Therapeutics, Inc. Deferred Tax Assets, Deferred Income
Alaunos Therapeutics, Inc. (TCRT) had Deferred Tax Assets, Deferred Income of $0 as of 2018-12-31, per its 10-K filed 2019-03-05.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2019-03-05
- 2018-12-31: Deferred Tax Assets, Deferred Income $0.00.
- 2017-12-31: Deferred Tax Assets, Deferred Income $11.13M.
- 2016-12-31: Deferred Tax Assets, Deferred Income $18.64M.
- 2015-12-31: Deferred Tax Assets, Deferred Income $2.69M.
| Period end | Deferred Tax Assets, Deferred Income |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-05 |
| 2017-12-31 | $11.13M 10-K · filed 2019-03-05 |
| 2016-12-31 | $18.64M 10-K · filed 2018-03-01 |
| 2015-12-31 | $2.69M 10-K · filed 2017-02-16 |
| 2014-12-31 | $534.00K 10-K · filed 2016-02-24 |
| 2013-12-31 | $1.07M 10-K · filed 2015-02-26 |
| 2012-12-31 | $1.39M 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |